Syros Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Syros Pharmaceuticals Inc
TickerSYRS
CIK #0001556263
CUSIP87184Q206
SectorLife Sciences - Pharmaceutical Preparations
Address480 Arsenal Street Suite 130, Watertown, MA 02472
Source [EDGAR]
CIK Filing 2011 - 2025
[0001556263] 10-K
[0001556263] 10-Q
[0001556263] 3
[0001556263] 4
[0001556263] 5
[0001556263] 8-K
[0001556263] D
[0001556263] SC 13D
[0001556263] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Blue Owl Capital Holdings LP Syros Pharmaceuticals Inc [2024-02-14] 5.74
Point72 Asset Management LP Syros Pharmaceuticals Inc [2024-01-02] 5.7
Samsara Biocapital LP Syros Pharmaceuticals Inc [2023-10-20] 7.4
Adage Capital Partners GP LLC Syros Pharmaceuticals Inc [2023-01-25] 6.04
Avidity Partners Management LP Syros Pharmaceuticals Inc [2022-09-20] 0.9
Deep Track Capital LP Syros Pharmaceuticals Inc [2022-09-19] 0.99
Syros Pharmaceuticals Inc TYME Technologies Inc [2022-07-13] 0.9
TYME Technologies Inc Syros Pharmaceuticals Inc [2022-07-13] 28.0
BlackRock Inc Syros Pharmaceuticals Inc [2022-07-08] 2.4
Artal International SCA Syros Pharmaceuticals Inc [2022-02-11] 5.6
Ally Bridge Medalpha Master Fund LP Syros Pharmaceuticals Inc [2020-12-18] 5.4
Bain Capital Life Sciences Fund II LP Syros Pharmaceuticals Inc [2020-12-14] 9.99
Point72 Asset Management LP Syros Pharmaceuticals Inc [2020-04-02] 5.1
BlackRock Inc Syros Pharmaceuticals Inc [2020-02-07] 6.7
Sumitomo Mitsui Trust Holdings Inc Syros Pharmaceuticals Inc [2019-09-09] 10.15
Nikko Asset Management Americas Inc Syros Pharmaceuticals Inc [2019-09-06] 10.15
Flynn James E Syros Pharmaceuticals Inc [2019-04-09] 0.9
ARK Investment Management LLC Syros Pharmaceuticals Inc [2019-02-14] 7.31
BlackRock Inc Syros Pharmaceuticals Inc [2019-02-08] 5.9
Polaris Partners VII LP Syros Pharmaceuticals Inc [2016-07-14] 6.8
FMR LLC Syros Pharmaceuticals Inc [2016-07-11] 0.0
Flagship Ventures Fund IV General Partner LLC Syros Pharmaceuticals Inc [2016-07-11] 20.6
Flynn James E Syros Pharmaceuticals Inc [2016-07-06] 2.69
Form 3/4/5 Filer 2011 - 2025
Simonian Nancy A
Syros Pharmaceuticals, Inc.
Quirk Gerald E
Chee Conley
Haas Jason
Stephens Kristin
Roth David
Akkaraju Srinivas
Young Richard A
Dunsire Deborah
Wirth Peter
Fanucci Marsha
Eckhardt Sue Gail
Tyson Timothy
OH Andrew M
Alles Mark J
Olson Eric R
Sharp Phillip A
Nashat Amir
Springhorn Jeremy P.
Ferra Joseph J Jr
ARCH Venture Partners VII, LLC
Crandell Keith
ARCH Venture Fund VII, L.P.
ARCH Venture Partners VII, L.P.
Nelsen Robert
Bybee Clinton
Shaw Alice Tsang
Sato Vicki L
Bonney Michael W
Afeyan Noubar
DeSimone Colleen Elizabeth
Flagship Ventures Fund IV-Rx, L.P.
Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV, L.P.
Kania Edwin M Jr
Flagship VentureLabs IV, LLC
Patel Sanj K
Kuvalanka Kyle D.
Bancel Stephane
Polaris Entrepreneurs' Fund VII, L.P.
Polaris Management Co. VII, L.L.C.
Polaris Partners VII, L.P.
WuXi PharmaTech Healthcare Fund I L.P.
Redmile Group, LLC
Green Jeremy
Schiff Andrew N
Aisling Capital III LP
Aisling Capital Partners III LP
Elms Steve
Aisling Capital Partners III LLC
Purcell Dennis J
Deerfield Mgmt L.P.
Flynn James E
Deerfield Mgmt III, L.P.
Deerfield Special Situations Fund, L.P.
Deerfield Management Company LP
Deerfield Private Design Fund III, L.P.
WuXi Healthcare Ventures II, L.P.
JEB Syros Trust
Perspecta Trust LLC
Conde Jorge
Gray Nathanael
Form 13F Holdings
Firm Period DFND Voting Shares
Osaic Holdings Inc [2025-06-30] DFND 0 113
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com